الملخص
Purpose: The purpose of this study was to evaluate the outcome of intravitreal (IVT) triamcinolone in diabetic macular edema (DME). Materials and methods: A retrospective study of 42 eyes diagnosed clinically and supported with optical coherence tomography (OCT), with DME of more than 300 μm in thickness. All eyes were injected with a single IVT injection of preservative free triamcinolone acetonide (TA) with dose of 4 mg. Patients were subjected to visual acuity (VA) and OCT on each follow-up visit which was continued for 6 months. The total number of IVT injections given was 48. Six eyes had a repeat injection. None of the eyes had any other IVT injection within 6 weeks of TA. Twenty-one eyes were pseudophakic. Results: Mean age of the patients was 58.8 years. The mean central subfield thickness (CST) at baseline was 504.6 μm. At 6 weeks, the mean CST dropped by 183.6 μm (P < 0.00001). At 6-month follow-up, the mean CST had increased by 74.6 μm from 6 weeks level; however, the 6-month mean CST was 109 μ less than mean baseline thickness (P < 0.0005). The mean baseline VA was 0.80 LogMAR units. At 6 weeks, the mean VA dropped by 0.01 LogMAR. At 6 months, VA improved by 0.02 LogMAR units from baseline. Overall, VA improved in 47% eyes, dropped from baseline in 35% eyes, and remained unchanged in 18% eyes. Conclusion: Triamcinolone acetonide is a safe, effective, and promising therapy in DME.
الكلمات المفتاحية
بيانات النشر
- المعرّف الرقمي
- 10.4103/ojo.ojo_173_2016
- المجلة
- المجلة العُمانية لطب العيون, 10(3), 177-183
- الناشر
- منشورات ميدنو
- وصول مفتوح
- وصول مفتوح ذهبي
اقتبس هذه المقالة
APA 7
Al-Hinai, A., Wali, U. K., Rasool, T. A., & Rizvi, S. G. (2017). Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population. Oman Journal of Ophthalmology, 10(3), 177-183. https://doi.org/10.4103/ojo.ojo_173_2016
MLA 9
Al-Hinai, Ahmed, et al. "Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population." Oman Journal of Ophthalmology, vol. 10, no. 3, 2017, pp. 177-183. https://doi.org/10.4103/ojo.ojo_173_2016.
شيكاغو (المؤلف–التاريخ)
Al-Hinai, Ahmed, Upender Krishen Wali, Tayseer Abdul Rasool, and Syed G. Rizvi. 2017. "Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population." Oman Journal of Ophthalmology 10 (3): 177-183. https://doi.org/10.4103/ojo.ojo_173_2016.
هارفارد
Al-Hinai, A., Wali, U. K., Rasool, T. A. and Rizvi, S. G. (2017) 'Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population', Oman Journal of Ophthalmology, 10(3), pp. 177-183. doi:10.4103/ojo.ojo_173_2016.
فانكوفر
Al-Hinai A, Wali UK, Rasool TA, Rizvi SG. Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population. Oman Journal of Ophthalmology. 2017;10(3):177-183. doi:10.4103/ojo.ojo_173_2016
IEEE
A. Al-Hinai, U. K. Wali, T. A. Rasool, and S. G. Rizvi, "Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population," Oman Journal of Ophthalmology, vol. 10, no. 3, pp. 177-183, 2017, doi: 10.4103/ojo.ojo_173_2016.